Clinical Trial Update: Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

The Hector study, a Phase 3 trial evaluating octreotide in patients with inoperable hepatocellular carcinoma, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: COMPLETED